Professor Andrew Grigg is the head of unit and is responsible for policy and trial activity for chronic lymphocytic leukaemia (CLL), chronic myeloid leukaemia (CML) and myeloproliferative diseases such as polycythaemia and essential thrombocytosis. In addition he has particular research and clinical interests in lymphoma (as part of the lymphoma service) and both autologous and allogeneic transplantation.
Dr Simon He heads the Bone Marrow Transplantation service. He also has a specific interest in immune-mediated cytopenias and TTP.
Dr Andrew Lim is a senior clinical haematologist and the medical lead for myeloma, with a focus on policy development and expansion of clinical trial activity in this disease. He also has substantial clinical experience in allogeneic transplantation.
Dr. Chun Fong is a senior clinical haematologist and the medical lead for acute leukaemia and myelodysplasia. He has substantial experience in basic science and translational research. He also has a strong interest in establishing new diagnostic technologies and works closely with partners at ONJCRI and Austin Pathology.
Dr Daniela Zantomio is a senior clinical haematologist with broad interests and is the medical lead in apheresis.
As the Lymphoma Medical Lead, Dr Eliza Hawkes has developed a dedicated lymphoma service at Austin Health, responsible for both lymphoma policy and clinical trial development. Outside of the Austin, she also holds the latter position at Eastern Health where she is the chair of the Lymphoma Multidisciplinary Meeting (MDM).
Eric has a specific interest and expertise in allogeneic transplantation and immunological approaches to reduce the risk of relapse. He also works as a general haematologist within the department.
Abbey is doing her PhD in thrombosis and has newly joined our team as the head of our Thrombosis and Haemostasis section. As per all consultants, she will also work as a general haematologist within the department.
Professor Anthony Schwarer is a senior clinical haematologist with a part-time appointment as one of the team responsible for care of our allograft patients.
Dr Paul Turner is a part-time senior clinical haematologist with an appointment in outpatients.
Peter Shuttleworth is our nurse consultant with many years of experience in haematology and bone marrow transplantation. His role includes donor searches and education and preparation of patients undergoing allogeneic bone marrow transplantation.
Priscilla is a nurse consultant with many years' experience in haematology. Her role includes education and coordination of patients' care undergoing stem cell collection and autologous stem cell transplantation and running a nurse led survivorship clinic (available to all relevant patients within the unit) to support patients and their families at completion of their treatment.
Tania Cushion is our Lymphoma Nurse Consultant with years of experience in Haematology. Tania provides personalised support, education and a point of contact for our patients and families with lymphoma and Chronic Lymphocytic Leukaemia (CLL).
Vanessa is a highly experienced nurse whose role is to provide education and support for our patients and families focusing on those with acute leukaemia and myelodysplasia.
Lindsay's role is to provide education and support for our patients and families with myeloma and in due course, myeloproliferative disease.
Stella's main responsibility is to collate data that relates to a patient's BMT (Bone Marrow Transplant) or PBSCT (Peripheral blood stem cell transplants) performed at Austin Health and enter this data into national and international registries that Austin health is participating in. It is vital that this data is reliable, reproducible and readily available to clinicians.
Natalie's role is to provide administrative support for the department including coordination of team and external stakeholder meetings, staff rostering as well as HR and payroll requirements. A key part of her role involves assisting patients with their queries to ensure that their care requirements are being met by our clinicians.